Mumbai, December 14, 2017:Pharma firm, JB Chemicals & Pharmaceuticals has received USFDA approval for its Supplementary Abbreviated New Drug Application (sANDA) for Atenolol Tablets USP 25 mg. 50 mg.and 100 mg. (anti-hypertensive) manufactured using company’s own bulk drug (API).

The company had initiated this change as a part of its plan to gradually backward integrate US formulations business.

United News of India